CRNX CRINETICS PHARMACEUTICALS INC Management Changes 8-K Filing 2024 - Management Plan Approval Crinetics Pharmaceuticals, Inc. approved the adoption of the Crinetics Pharmaceuticals, Inc. Excess Deferral Plan, a non-qualified deferred compensation plan for select management and highly compensated employees.Get access to all SEC 8-K filings of the CRINETICS PHARMACEUTICALS INC